Dimensional Fund Advisors LP Has $175.33 Million Stock Position in Hologic, Inc. $HOLX

Key Points

• Dimensional Fund Advisors LP increased its stake in Hologic, Inc. by 8.1% in Q1, resulting in ownership of approximately 2.84 million shares valued at $175.33 million.
• Hologic reported $1.08 EPS for the last quarter, surpassing expectations, while revenue increased by 1.2% year-over-year.
• Currently, Hologic has a consensus rating of "Moderate Buy" among analysts, with an average target price of $78.00.

Dimensional Fund Advisors LP lifted its position in Hologic, Inc. (NASDAQ:HOLX - Free Report) by 8.1% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,838,656 shares of the medical equipment provider's stock after buying an additional 213,366 shares during the period. Dimensional Fund Advisors LP owned about 1.27% of Hologic worth $175,331,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Farther Finance Advisors LLC increased its position in shares of Hologic by 22.3% in the 1st quarter. Farther Finance Advisors LLC now owns 1,835 shares of the medical equipment provider's stock valued at $113,000 after buying an additional 335 shares in the last quarter. SG Americas Securities LLC increased its position in shares of Hologic by 116.6% in the 1st quarter. SG Americas Securities LLC now owns 9,609 shares of the medical equipment provider's stock valued at $594,000 after buying an additional 5,172 shares in the last quarter. Brevan Howard Capital Management LP increased its holdings in Hologic by 85.5% during the 4th quarter. Brevan Howard Capital Management LP now owns 19,436 shares of the medical equipment provider's stock worth $1,401,000 after purchasing an additional 8,960 shares in the last quarter. Cambridge Investment Research Advisors Inc. increased its holdings in Hologic by 1.7% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 32,056 shares of the medical equipment provider's stock worth $1,980,000 after purchasing an additional 528 shares in the last quarter. Finally, Teachers Retirement System of The State of Kentucky increased its holdings in Hologic by 4.5% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 17,945 shares of the medical equipment provider's stock worth $1,108,000 after purchasing an additional 767 shares in the last quarter. Institutional investors own 94.73% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on HOLX. Needham & Company LLC reiterated a "hold" rating on shares of Hologic in a report on Tuesday, May 27th. Mizuho set a $75.00 target price on Hologic in a report on Thursday, July 31st. Royal Bank Of Canada upgraded Hologic from a "sector perform" rating to an "outperform" rating and increased their target price for the stock from $72.00 to $87.00 in a report on Wednesday, August 6th. Evercore ISI increased their target price on Hologic from $62.00 to $68.00 and gave the stock an "in-line" rating in a report on Tuesday, July 8th. Finally, UBS Group increased their target price on Hologic from $65.00 to $70.00 and gave the stock a "neutral" rating in a report on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and eight have given a Hold rating to the company's stock. According to MarketBeat.com, Hologic currently has a consensus rating of "Moderate Buy" and an average price target of $78.00.

Hologic Stock Up 1.6%

Shares of NASDAQ HOLX traded up $1.09 during mid-day trading on Friday, hitting $68.26. The company had a trading volume of 1,545,907 shares, compared to its average volume of 1,851,908. The company has a market capitalization of $15.18 billion, a PE ratio of 28.32, a price-to-earnings-growth ratio of 2.48 and a beta of 0.49. The firm has a 50-day simple moving average of $65.90 and a two-hundred day simple moving average of $62.42. The company has a current ratio of 3.55, a quick ratio of 2.81 and a debt-to-equity ratio of 0.52. Hologic, Inc. has a one year low of $51.90 and a one year high of $84.39.

Hologic (NASDAQ:HOLX - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $1.08 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.03. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.01 billion. Hologic had a return on equity of 19.69% and a net margin of 13.79%.Hologic's revenue for the quarter was up 1.2% compared to the same quarter last year. During the same quarter last year, the company earned $1.06 EPS. Hologic has set its Q4 2025 guidance at 1.090-1.120 EPS. FY 2025 guidance at 4.230-4.260 EPS. On average, equities analysts expect that Hologic, Inc. will post 4.28 EPS for the current year.

Hologic Company Profile

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth.